Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Shift to Everolimus (RAD) Kidney Sparing Study

This study has been terminated.
(A cluster of adverse events in everolimus arm was noted.)
Sponsor:
Information provided by:
University of Bologna
ClinicalTrials.gov Identifier:
NCT00420537
First received: January 9, 2007
Last updated: January 11, 2010
Last verified: May 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2009
  Primary Completion Date: January 2009 (Final data collection date for primary outcome measure)